Skip Header

1 - 25 of 28 results for author:"Tada K." in Literature citations

Page of 2 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (13)

MK615, a Prunus mume Steb. Et Zucc ('Ume') extract, attenuates the growth of A375 melanoma cells by inhibiting the ERK1/2-Id-1 pathway.

Tada K., Kawahara K., Matsushita S., Hashiguchi T., Maruyama I., Kanekura T.

Phytother Res 26:833-838(2012) · Mapped (6)

Condensin association with histone H2A shapes mitotic chromosomes.

Tada K., Susumu H., Sakuno T., Watanabe Y.

Nature 474:477-483(2011) · Mapped (7)

Association of the clusterin gene polymorphisms with type 2 diabetes mellitus.

Daimon M., Oizumi T., Karasawa S., Kaino W., Takase K., Tada K., Jimbu Y., Wada K., Kameda W., Susa S. et al.

Metab. Clin. Exp. 60:815-822(2011) · Mapped (5)

Fibronectin/integrin system is involved in P2X(4) receptor upregulation in the spinal cord and neuropathic pain after nerve injury.

Tsuda M., Toyomitsu E., Komatsu T., Masuda T., Kunifusa E., Nasu-Tada K., Koizumi S., Yamamoto K., Ando J., Inoue K.

Glia 56:579-585(2008) · Mapped (9)

Identification of Tim4 as a phosphatidylserine receptor.

Miyanishi M., Tada K., Koike M., Uchiyama Y., Kitamura T., Nagata S.

Nature 450:435-439(2007) · UniProtKB (1) · Mapped (6)

UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.

Koizumi S., Shigemoto-Mogami Y., Nasu-Tada K., Shinozaki Y., Ohsawa K., Tsuda M., Joshi B.V., Jacobson K.A., Kohsaka S., Inoue K.

Nature 446:1091-1095(2007) · Mapped (2)

RUNX3 protein is overexpressed in human basal cell carcinomas.

Salto-Tellez M., Peh B.K., Ito K., Tan S.H., Chong P.Y., Han H.C., Tada K., Ong W.Y., Soong R., Voon D.C. et al.

Oncogene 25:7646-7649(2006) · Mapped (5)

Possible involvement of increase in spinal fibronectin following peripheral nerve injury in upregulation of microglial P2X4, a key molecule for mechanical allodynia.

Nasu-Tada K., Koizumi S., Tsuda M., Kunifusa E., Inoue K.

Glia 53:769-775(2006) · Mapped (6)

RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.

Ito K., Liu Q., Salto-Tellez M., Yano T., Tada K., Ida H., Huang C., Shah N., Inoue M., Rajnakova A. et al.

Cancer Res. 65:7743-7750(2005) · Mapped (5)

Tethering of apoptotic cells to phagocytes through binding of CD47 to Src homology 2 domain-bearing protein tyrosine phosphatase substrate-1.

Tada K., Tanaka M., Hanayama R., Miwa K., Shinohara A., Iwamatsu A., Nagata S.

J. Immunol. 171:5718-5726(2003) · Mapped (13)

Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1.

Tada K., Kochi M., Saya H., Kuratsu J., Shiraishi S., Kamiryo T., Shinojima N., Ushio Y.

Neuro-oncology 5:228-234(2003) · Mapped (10)

Expression of Hqk encoding a KH RNA binding protein is altered in human glioma.

Li Z.Z., Kondo T., Murata T., Ebersole T.A., Nishi T., Tada K., Ushio Y., Yamamura K., Abe K.

Jpn. J. Cancer Res. 93:167-177(2002) · UniProtKB (1)

Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death.

Tada K., Okazaki T., Sakon S., Kobarai T., Kurosawa K., Yamaoka S., Hashimoto H., Mak T.W., Yagita H., Okumura K. et al.

J. Biol. Chem. 276:36530-36534(2001) · Mapped (8)

A novel alternatively spliced fibroblast growth factor receptor 3 isoform lacking the acid box domain is expressed during chondrogenic differentiation of ATDC5 cells.

Shimizu A., Tada K., Shukunami C., Hiraki Y., Kurokawa T., Magane N., Kurokawa-Seo M.

J. Biol. Chem. 276:11031-11040(2001) · UniProtKB (1) · Mapped (10)

Schnurri interacts with Mad in a Dpp-dependent manner.

Udagawa Y., Hanai J., Tada K., Grieder N.C., Momoeda M., Taketani Y., Affolter M., Kawabata M., Miyazono K.

Genes Cells 5:359-369(2000) · Mapped (14)

Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor.

Hirota T., Morisaki T., Nishiyama Y., Marumoto T., Tada K., Hara T., Masuko N., Inagaki M., Hatakeyama K., Saya H.

J. Cell Biol. 149:1073-1086(2000) · UniProtKB (1)

Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation.

Nakano H., Sakon S., Koseki H., Takemori T., Tada K., Matsumoto M., Munechika E., Sakai T., Shirasawa T., Akiba H. et al.

Proc. Natl. Acad. Sci. U.S.A. 96:9803-9808(1999) · Mapped (9)

Association between drinking-related antisocial behavior and a polymorphism in the serotonin transporter gene in a Japanese population.

Ishiguro H., Saito T., Akazawa S., Mitushio H., Tada K., Enomoto M., Mifune H., Toru M., Shibuya H., Arinami T.

Alcohol. Clin. Exp. Res. 23:1281-1284(1999) · Mapped (3)

Selective expression of a novel surface molecule by human Th2 cells in vivo.

Nagata K., Tanaka K., Ogawa K., Kemmotsu K., Imai T., Yoshie O., Abe H., Tada K., Nakamura M., Sugamura K. et al.

J. Immunol. 162:1278-1286(1999) · UniProtKB (1)

Systematic search for variations in the tyrosine hydroxylase gene and their associations with schizophrenia, affective disorders, and alcoholism.

Ishiguro H., Arinami T., Saito T., Akazawa S., Enomoto M., Mitushio H., Fujishiro H., Tada K., Akimoto Y., Mifune H. et al.

Am. J. Med. Genet. 81:388-396(1998) · UniProtKB (1)

A one-base deletion (183delC) and a missense mutation (D276H) in the T-protein gene from a Japanese family with nonketotic hyperglycinemia.

Kure S., Shinka T., Sakata Y., Osamu N., Takayanagi M., Tada K., Matsubara Y., Narisawa K.

J. Hum. Genet. 43:135-137(1998) · UniProtKB (1)

A missense mutation (His42Arg) in the T-protein gene from a large Israeli-Arab kindred with nonketotic hyperglycinemia.

Kure S., Mandel H., Rolland M.-O., Sakata Y., Shinka T., Drugan A., Boneh A., Tada K., Matsubara Y., Narisawa K.

Hum. Genet. 102:430-434(1998) · UniProtKB (1)

The molecular defect in propionic acidemia: exon skipping caused by an 8-bp deletion from an intron in the PCCB allele.

Ohura T., Ogasawara M., Ikeda H., Narisawa K., Tada K.

Hum. Genet. 92:397-402(1993) · UniProtKB (1)

Defective gene in lactic acidosis: abnormal pyruvate dehydrogenase E1 alpha-subunit caused by a frame shift.

Endo H., Hasegawa K., Narisawa K., Tada K., Kagawa Y., Ohta S.

Am. J. Hum. Genet. 44:358-364(1989) · UniProtKB (1)

Identification of a common mutation in patients with medium-chain acyl-CoA dehydrogenase deficiency.

Matsubara Y., Narisawa K., Miyabayashi S., Tada K., Coates P.M., Bachmann C., Elsas L.J. II, Pollitt R.J., Rhead W.J., Roe C.R.

Biochem. Biophys. Res. Commun. 171:498-505(1990) · UniProtKB (1)

to top of page·

Page of 2 | Next »